Boothbay Fund Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-31,607
Closed -$35.4K 1694
2024
Q4
$35.4K Buy
+31,607
New +$27K ﹤0.01% 1395
2022
Q3
Sell
-20,712
Closed -$28K 2523
2022
Q2
$28K Buy
20,712
+3,666
+22% +$5.44K ﹤0.01% 2167
2022
Q1
$36K Buy
+17,046
New +$41.5K ﹤0.01% 2209

Other funds holding PGEN

Boothbay Fund Management's PGEN Position: Q1 2025 in Review

Boothbay Fund Management sold out of Precigen (PGEN) in Q1 2025, closing a stake of 31,607 shares — an estimated $35.4K sold.

Boothbay Fund Management first reported a position in PGEN in Q1 2022 and held it in 3 quarters. The position peaked at $36K in Q1 2022. 138 funds tracked by Wall St. Rank hold PGEN as of Q1 2025.

  • Boothbay Fund Management reported no remaining Precigen position as of Q1 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 31,607 Precigen shares in Q1 2025, an estimated $35.4K.
  • Boothbay Fund Management first reported a position in Precigen in Q1 2022 and held it in 3 quarters.
  • Boothbay Fund Management's Precigen position peaked at $36K in Q1 2022.
  • 138 funds tracked by Wall St. Rank held Precigen as of Q1 2025.

Based on Boothbay Fund Management's 13F filing for Q1 2025, filed 15 May 2025.